Accretion Nutraveda Limited announced that its shareholders have approved five special resolutions through a postal ballot process concluded on October 10, 2026. The approvals cover critical corporate actions, including the alteration of the Memorandum of Association (MOA), an increase in borrowing limits, and the creation of mortgages on company assets.

The e-voting period ran from September 10, 2026, to October 9, 2026, facilitated by Central Depository Services (India) Limited (CDSL). Mr. Harshad Rathod, Chairman of the company, declared the results based on the scrutinizer’s report submitted by CS Nimish Chunibhai Sakhia of M/s Sakhya & Co.

Voting outcomes

All five special resolutions were passed with a 100% majority in favour. Notably, the resolution regarding the advancement of loans or guarantees to subsidiaries under Section 185 of the Companies Act, 2013, saw significantly lower participation compared to the other items, with only 3,000 valid votes cast in favour versus 5,323,000 for the other resolutions.

Details of MOA alteration

The approved alteration specifically amends Clause III (Object Clause) of the MOA. The Main Object Clause III(A) has been substituted to explicitly include the manufacturing and trading of nutraceuticals, dietary supplements, Ayurvedic, Homeopathic, Unani, Allopathic, herbal, and wellness products. It also covers pharmaceuticals, bulk drugs, intermediates, cosmetics, medical devices, and diagnostic kits. Furthermore, the company is authorized to establish hospitals, nursing homes, diagnostic centres, and research laboratories.

New sub-clauses under Clause III(B), numbered 58 to 69, have been inserted to support these main objects. These include powers to invest in securities, acquire land and machinery, undertake backward and forward integration, and engage in agricultural activities such as cultivating herbs, medicinal plants, and other produce required for the business. The amendment also permits the company to act as traders, merchants, and agents, and to establish agencies for sale and purchase operations.

What the Numbers Show

The voting data reveals a distinct divergence in shareholder engagement across the proposed resolutions. While Items 1, 2, 3, and 5 attracted 5,323,000 valid votes each, Item 4 regarding subsidiary financial support recorded only 3,000 valid votes. This disparity suggests that while the broader corporate restructuring and borrowing mandates had near-unanimous support from the voting base, the specific provision for extending credit to subsidiaries either affected a much smaller subset of eligible voters or was not prioritized by the majority of participating shareholders, despite passing with full consensus among those who voted.

Accretion Nutraveda Limited has issued a postal ballot notice seeking shareholder approval to enhance its borrowing limits to ₹500 crore and alter its Memorandum of Association. The e-voting period for these special resolutions runs from September 10, 2026, to October 9, 2026.

The company aims to secure adequate financial flexibility for business expansion, organic growth initiatives, and future funding requirements. The proposed borrowing limit represents an increase from the existing limit of ₹50 crore, calculated as an amount in excess of the aggregate of paid-up share capital, free reserves, and share premium.

Key Resolutions

Shareholders are being asked to approve five special resolutions through remote e-voting facilitated by Central Depository Services (India) Limited (CDSL). The key items include:

• Alteration of MOA: Expansion of object clauses to include broader activities in nutraceuticals, pharmaceuticals, healthcare services, and agricultural produce processing.
• Borrowing Limits: Enhancement of borrowing capacity under Section 180(1)(c) of the Companies Act, 2013, up to ₹500 crore in excess of capital and reserves.
• Creation of Charge: Authorization to create mortgages or charges on movable and immovable properties to secure borrowings.
• Loans to Subsidiaries: Approval to advance loans or provide guarantees to subsidiaries and group companies up to ₹100 crore under Section 185.
• Loans and Investments: Permission to give loans, guarantees, or make investments in other bodies corporate up to ₹100 crore under Section 186.

Voting Process

The cut-off date for determining voting rights is September 4, 2026. Members holding shares as on this date are eligible to vote. The e-voting module will be disabled after the deadline on October 9, 2026, at 5:00 pm.

The company stated that the alteration of the MOA does not involve any diversion of proceeds raised through its Initial Public Offer (IPO). Unutilised IPO proceeds will continue to be deployed strictly towards the original objects stated in the prospectus.